Search Results - Emmanuel Valentin
- Showing 1 - 4 results of 4
-
1
687 Enhancement of anti-tumor immunity by ICT01: a novel g9d2 T cell-activating antibody targeting butyrophilin-3A (BTN3A) by Jennifer Sims, Patrick Brune, René Hoet, Emmanuel Valentin, LE Suong, Sophie Agaugué, Remy Castellano, Alem Truneh
Published in Journal for ImmunoTherapy of Cancer (2020-11-01)Article -
2
3 Butyrophilin-3a is expressed in multiple solid tumors: translational research supporting the EVICTION study with ICT01, an anti-BTN3A mAb activating Vg9Vd2 T-Cells by Clement Ghigo, Aude de Gassard, Patrick Brune, Clemence Demerle, ROUVIERE Marie-Sarah, René Hoet, Emmanuel Valentin
Published in Journal for ImmunoTherapy of Cancer (2020-11-01)Article -
3
316 EVICTION Study: Preliminary results in solid tumor patients with ICT01, a first-in-class, gamma9 delta2 T cell activating antibody targeting butyrophilin-3A by Aurélien Marabelle, Martin Wermke, Aude de Gassart, Daniel Olive, Patrick Brune, Emmanuel Valentin, Paul Frohna, Christiane Jungels, Norbert Vey, Elena Garralda, Marina Iché
Published in Journal for ImmunoTherapy of Cancer (2020-11-01)Article -
4
715 ICT01 plus low dose SC IL-2 produces a robust anti-tumor immune activation in advanced cancer patients (EVICTION-2 Study) by Stephane Champiat, Francois-Xavier Danlos, Volker Kunzmann, Martin Wermke, Aude de Gassart, Daniel Olive, Patrick Brune, Emmanuel Valentin, Johann De Bono, Paul Frohna, Marina Iché, Maelle Mairesse, Celine Leparquier, Katrien Lemmens
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article